Castleman disease (CD) describes a group of heterogeneous hematologic disorders with
characteristic histopathological features. CD can present with unicentric or multicentric …

Thrombocytopenia, anasarca, fever, reticulin fibrosis/renal failure, and organomegaly
(TAFRO) syndrome is rare in clinical practice. It is a systemic inflammatory disease caused …

Background Castleman disease (CD) is a rare polyclonal lymphoproliferative disorder with
unknown etiology. TAFRO syndrome is now regarded as a specific subtype of CD, and is still …

POEMS (polyneuropathy, organomegaly, endocrinopathy monoclonal gammopathy, and
skin changes) syndrome is occasionally associated with Castleman disease (CD) and their …

Castleman disease describes a group of heterogeneous clinicopathological disorders now
included in the tumor-like lesions with B-cell predominance of the World Health Organization …

Interventions: She was treated with combination of tocilizumab, lenalidomide, and
glucocorticoids. Outcomes: This patient achieved complete remission (CR) with all her …

一线治疗失败或复发的老年多中心型Castleman 病(MCD) 患者尚无标准的治疗方案,
国外文献报道来那度胺对于复发/难治的MCD 有一定疗效, 但中文文献报道较少. 本文报道2 …

No standard therapy is recommended for elderly multicentric Castleman's disease (MCD)
patients who failed to the first-line treatment or relapsed. Lenalidomide has been reported to …

Castleman disease is a very rare, lymphoproliferative disease, driven by dysregulation of the
cytokine interleukin 6 (IL-6) and other proinflammatory cytokines with the development of …

CD20-negative diffuse large B-cell lymphoma (DLBCL) is a rare and heterogeneous group
of aggressive lymphoproliferative disorders. Described variants of CD20-negative DLBCL …